上海厦泰生物科技有限公司
屏蔽该公司
取消屏蔽

医疗器械· 100-499人· 美股上市

Cytek Biosciences is a high-tech enterprise engaged in the development, production, sales and after-sales service of flow cytometers and supporting solutions. Its headquarter is located in Silicon Valley, USA, and R&D and marketing service center in Shanghai, manufacturing sites in Wuxi, branches in Tokyo, Japan and Amsterdam, Netherlands. Cytek Biosciences is committed to providing powerful solutions that enable scientists to rapidly and efficiently obtain deep biological insights through high quality, high parametric datasets. We are on a mission to advance cancer and cell biology research using a powerful cell analysis technique called full spectrum flow cytometry. We have successively developed and launched DxP AthenaTM traditional flow cytometry analyzers, CytekTM Aurora series full-spectrum flow cytometry analyzers, CytekTM Northern Lights series and other full-spectrum flow cytometry analyzers, related diagnostic reagents and other products, our full-spectrum flow cytometry The cytometer is hailed as a revolutionary and innovative product in the industry, and has been sold to key scientific research institutions, pharmaceutical companies and CRO companies on four continents around the world. Cytek Biosciences is a young and energetic foreign-funded enterprise. The company is inseparable from the talents with innovative ability, hard work spirit and teamwork spirit. Welcome to join us with the pursuit of dreams and challenges. The company provides you with broad development platform, perfect welfare and competitive treatment. We look forward to working together with you to create a better future.
...
查看全部 收起
融资情况
112020
D轮 1.2亿美元
投资机构: 奥博资本
092018
C轮 未披露
投资机构: LLC / 北极光创投 / 本草资本
  
融资时间线